Screener
Discontinued — last reported Q1 '26
EBIT at other companies
Other financials
Where this comes from
Calculated from USANA Health Sciences’s reported figures.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
FAQ
- What is USANA Health Sciences's EBIT?
- USANA Health Sciences (USNA) reported EBIT of $13.87M in Q1 2026.
- How has USANA Health Sciences's EBIT changed year-over-year?
- USANA Health Sciences's EBIT decreased by 11.5% year-over-year, from $15.67M to $13.87M.
- What is the long-term trend for USANA Health Sciences's EBIT?
- Over 3 years (2022 to 2025), USANA Health Sciences's EBIT has grown at a -29.7% compound annual growth rate (CAGR), from $107.61M to $37.43M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about USANA Health Sciences's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude